Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid vs nonsteroidal anti-inflammatory eye drops after cataract surgery
2015-003296-30Phase 4Completed
- Sponsor
- Raimo Tuuminen
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of nepafenac and prednisolone in senile cataract (ARC), Postoperative ocular inflammation, Irvine-Gass syndrome (IGS) and 1 more (3 arms), sponsored by Raimo Tuuminen. Primary endpoints: Best corrected visual acuity, Intraocular pressure and 2 more. Started Jul 2015; status: completed.
02
Drugs
nepafenacprednisolone
03
Conditions
senile cataract (ARC)Postoperative ocular inflammationIrvine-Gass syndrome (IGS)posterior capsule opacification (PCO)
Beyond the preview
Go deeper on 2015-003296-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003296-30.